CoxHealth has joined a national clinical trial to learn how convalescent plasma might help treat patients suffering from COVID-19. And it’s treating its first patient right now. The trial was initiated by the Mayo Clinic.
Dr. Anne Hayes, a pathologist at CoxHealth, said in a news release she hopes that what they learn through the trials will help them “develop treatment protocols to make a big difference in the months ahead.”
Researchers hope the antibodies in the plasma of recovered patients will help those battling severe or life-threatening cases of COVID-19.
People who have had COVID-19 and are now recovered are asked to donate convalescent plasma. They can contact their healthcare provider to find out how or email email@example.com.